STOCK TITAN

Medline (MDLN) Stock Price, News & Analysis

MDLN NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
17 229 sessions, December 17, 2025 to November 13, 2026
Largest daily move
+18.4% close of November 4, 2026
1-month change
+10.6% closing prices, October 13, 2026 to November 13, 2026

Company Description

Medline Inc. (Nasdaq: MDLN) is a healthcare company that focuses on medical-surgical ("med-surg") products and supply chain solutions for healthcare providers. According to the company, it is the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Medline’s activities center on helping healthcare organizations support patient care while addressing clinical, financial and operational needs.

Medline states that it serves a variety of healthcare settings, including hospitals, surgery centers, physician offices and post-acute care facilities. Its offerings include med-surg products and related supply chain services that are used in these environments to support day-to-day patient care and clinical procedures.

Business focus and segments

Based on available information, Medline operates through two primary segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment relates to the company’s own med-surg products, while the Supply Chain Solutions segment relates to services and capabilities that help healthcare providers manage the flow of these products. The company notes that its revenues are generated principally from the sale of its surgical products.

Within med-surg, Medline’s product portfolio includes surgical and procedural kits, gloves and protective apparel, urological and incontinence care products, wound care products, and consumable laboratory and diagnostics products. These products are positioned to support a broad range of clinical activities and care pathways across different types of healthcare facilities.

Role in the healthcare supply chain

Medline emphasizes its combination of a broad product portfolio, a resilient supply chain and what it describes as leading clinical solutions. Through these elements, the company aims to help healthcare providers improve clinical outcomes, manage costs and support operational performance. The focus on supply chain solutions reflects Medline’s role not only as a product supplier but also as a partner in managing product availability and logistics for healthcare organizations.

The company describes itself as serving "all points of care," which encompasses acute care, ambulatory care and post-acute care settings. By working across these settings, Medline positions its med-surg products and supply chain capabilities as relevant to the continuum of patient care.

Public company and listing information

Medline Inc. has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to an initial public offering of its common stock. The company has announced the pricing and closing of an upsized initial public offering of Class A common stock, and its Class A common stock is listed on the Nasdaq Global Select Market under the symbol "MDLN".

The company has indicated that proceeds from the initial public offering are intended for repayment of outstanding indebtedness under senior secured term loan facilities, for general corporate purposes and to cover expenses related to the offering. Medline has also stated that a portion of the proceeds will be used to purchase or redeem outstanding equity interests from certain pre-IPO owners.

Headquarters and global footprint

Medline is headquartered in Northfield, Illinois. The company reports that it employs more than 43,000 people worldwide and operates in more than 100 countries. This global footprint supports its position as a large provider of med-surg products and supply chain solutions to healthcare providers in multiple regions.

Healthcare settings served

According to the company’s description, Medline serves:

  • Hospitals that require med-surg products and supply chain support for inpatient and outpatient care.
  • Surgery centers that use surgical and procedural kits and related products.
  • Physician offices that need consumable products for examinations and minor procedures.
  • Post-acute care facilities, which include settings that care for patients after hospitalization.

By working with these settings, Medline aligns its product and supply chain solutions with the practical requirements of healthcare delivery.

Use of med-surg products

Med-surg products are used in a wide range of clinical situations, from routine examinations to complex procedures. Medline’s portfolio, as described in available information, covers areas such as:

  • Surgical and procedural kits, which bundle items needed for specific procedures.
  • Gloves and protective apparel, which support infection prevention and staff protection.
  • Urological and incontinence care, which support patient comfort and care management.
  • Wound care, which addresses treatment and management of various wound types.
  • Consumable lab and diagnostics products, which support testing and diagnostic workflows.

These categories reflect the company’s focus on products that are regularly consumed in healthcare operations.

IPO and capital structure context

Medline’s initial public offering of Class A common stock represents a transition to trading on a public market. The company has described an upsized offering and the full exercise of underwriters’ options to purchase additional shares. Information in the company’s announcements indicates that the offering is associated with debt repayment and transactions with pre-IPO owners, as well as general corporate purposes.

Investors and analysts interested in Medline can refer to the company’s registration statement on Form S-1 and related prospectus documents for more detailed information about its business, risk factors and financial statements.

Position within healthcare

According to Medline’s own statements, it is the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products. This characterization highlights the company’s scale within its specific niche of the healthcare industry. Its combination of med-surg products, supply chain capabilities and clinical solutions is presented as central to its role in supporting healthcare providers.

Stock Performance

$39.48
+0.03%
+0.01
After hoursChange vs the $39.47 closeLast updated: November 13, 2026 at 18:15
-6%
Performance this year
$51.9B

Medline (MDLN) closed at $39.47 on November 13, 2026. So far this year, the price has lost 6.0%.

See what a $1,000 investment in MDLN would be worth today

Average down calculator for MDLN

MDLN Metrics & Rankings

Price returns through November 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Insider Radar

Net Sellers
90-Day Summary
0
Shares Bought
28,495,617
Shares Sold
6
Transactions
Most Recent Transaction
GIC Private Ltd (10% Owner) sold 7,816,987 shares held indirectly @ $35.15 on October 8, 2026

Insider selling at Medline over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

Medline generated $28.4B in revenue in FY2025, retaining a 26.4% gross margin, and operating income reached $2.2B (7.8% operating margin). Diluted earnings per share stood at -$0.01. The company generated $1.7B in operating cash flow. The current ratio was 4.29, measuring current assets divided by current liabilities.

$28.4B
Revenue (FY2025)
$1.7B
Operating Cash Flow

Upcoming Events

NOV
17
November 17, 2026 Marketing

Jefferies Conference Presentation

CEO Jim Boyle presenting at Jefferies Healthcare Conference in London; webcast at ir.medline.com; replay available 120 days.
YEAR
2027
2027 Operations

Symbotic System pilot

Pilot of Symbotic System at one of Medline's 45 U.S. distribution centers in 2027; first healthcare deployment.
JAN
2027
January 2027 Operations

Stockton facility lease

709,000 sq ft leased facility in Stockton, CA slated for use starting January 2027; supports Northern California distribution.
Q2
2027
Q2 2027 Operations

Midlothian distribution center operational

1.2M sq ft Midlothian, TX distribution center; AutoStore automation; supports next-day delivery
YEAR
2027
2027 Operations

California footprint milestone

Medline expects California distribution footprint to reach ~5,000,000 sq ft by mid-2027; Perris site developed by IDI Logistics.
YEAR
2027
2027 Operations

Statewide capacity target

Medline expects statewide distribution capacity to approach 5,000,000 sq ft by mid-2027, including new Perris 1M site.
YEAR
2028
2028 Operations

Distribution center opening

Medline to begin serving from an ~800,000 sq ft Van Buren Township distribution center; Ashley Capital developing Crossroads North.

Medline has 7 upcoming scheduled events. The next event, "Jefferies Conference Presentation", is scheduled for November 17, 2026 (tomorrow). Investors can track these dates to stay informed about potential catalysts that may affect the MDLN stock price.

Short Interest History

Last 12 Months

Short interest in Medline (MDLN) currently stands at 37.8 million shares, down 7.3% from the previous reporting period, representing 4.3% of this share class. Since December 2025, short interest has increased by 193.7%.

Days to Cover History

Last 12 Months

Days to cover for Medline (MDLN) currently stands at 3.8 days, down 29.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since December 2025, the figure has increased by 279%. Across the settlements charted above, it has ranged from 1.0 to 6.8 days.

MDLN Company Profile & Sector Positioning

Medline (MDLN) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing MDLN often look at related companies in the same sector, including Becton, Dickinson and Co. (BDX), Alcon Inc. (ALC), ResMed Inc. (RMD), West Pharmaceutical Services, Inc. (WST), and Solventum Corporation (SOLV). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MDLN's relative position within its industry.

Frequently Asked Questions

The current stock price of Medline (MDLN) is $39.48 in after-hours trading as of November 13, 2026.

The market cap of Medline (MDLN) is approximately $51.9B. Learn more about what market capitalization means .

The FY2025 revenue of Medline (MDLN) is $28.4B, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Medline (MDLN) is -$0.01 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Medline (MDLN) is $1.7B for FY2025, its most recent completed fiscal year. Learn about cash flow.

The operating profit margin of Medline (MDLN) is 7.8% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Medline (MDLN) is 26.4% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Medline (MDLN), current assets divided by current liabilities, was 4.29 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Medline (MDLN) is $7.5B for FY2025, its most recent completed fiscal year.

The operating income of Medline (MDLN) is $2.2B for FY2025, its most recent completed fiscal year. Learn about operating income.

Medline Inc. focuses on medical-surgical ("med-surg") products and supply chain solutions for healthcare providers. The company describes itself as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.

Medline states that it serves hospitals, surgery centers, physician offices and post-acute care facilities. Its med-surg products and supply chain solutions are used across these settings to support patient care and clinical operations.

According to available information, Medline’s offerings include med-surg products such as surgical and procedural kits, gloves and protective apparel, urological and incontinence care products, wound care products, and consumable lab and diagnostics products.

Medline reports that its revenues are generated principally from the sale of its surgical products. These products are part of the company’s broader med-surg portfolio used in various healthcare settings.

Based on the information provided, Medline operates in two segments: Medline Brand and Supply Chain Solutions. Medline Brand relates to the company’s own med-surg products, while Supply Chain Solutions focuses on services that help manage the delivery and availability of these products.

Medline is headquartered in Northfield, Illinois. The company also reports that it employs more than 43,000 people worldwide and operates in more than 100 countries.

Medline’s Class A common stock is listed on the Nasdaq Global Select Market under the ticker symbol "MDLN."

Medline has stated that it intends to use proceeds from its initial public offering to repay outstanding indebtedness under its senior secured term loan facilities, for general corporate purposes and to cover offering expenses. A portion of the proceeds is also intended to purchase or redeem outstanding equity interests from certain pre-IPO owners.

Medline explains that through its broad product portfolio, resilient supply chain and clinical solutions, it helps healthcare providers improve their clinical, financial and operational outcomes.

When Medline refers to serving "all points of care," it is describing its presence across multiple care settings, including hospitals, surgery centers, physician offices and post-acute care facilities, where its med-surg products and supply chain solutions are used.